Autonomy, beneficence, justice, and the limits of provider profiling.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 22698493)

Published in J Am Coll Cardiol on June 19, 2012

Authors

David M Shahian1, Sharon-Lise T Normand

Author Affiliations

1: Center for Quality and Safety, Massachusetts General Hospital, Boston, 02114, USA. dshahian@partners.org

Articles by these authors

Screening for serious mental illness in the general population. Arch Gen Psychiatry (2003) 15.75

Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med (2014) 10.54

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11

An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes (2008) 6.00

Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission. Circ Cardiovasc Qual Outcomes (2009) 5.66

Pay for performance in commercial HMOs. N Engl J Med (2006) 5.52

An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with an acute myocardial infarction. Circulation (2006) 5.35

National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008. JAMA (2011) 5.16

Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. JAMA (2006) 5.06

Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation (2007) 4.74

An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with heart failure. Circulation (2006) 4.52

The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg (2009) 4.39

Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006. JAMA (2010) 4.36

Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. JAMA (2009) 4.24

Physician clinical performance assessment: prospects and barriers. JAMA (2003) 4.16

Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail (2009) 3.95

Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ (2005) 3.94

Behavioral health insurance parity for federal employees. N Engl J Med (2006) 3.77

Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med (2007) 3.71

Variability in the measurement of hospital-wide mortality rates. N Engl J Med (2010) 3.65

The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg (2009) 3.45

Standards for statistical models used for public reporting of health outcomes: an American Heart Association Scientific Statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group: cosponsored by the Council on Epidemiology and Prevention and the Stroke Council. Endorsed by the American College of Cardiology Foundation. Circulation (2005) 3.38

Recent declines in hospitalizations for acute myocardial infarction for Medicare fee-for-service beneficiaries: progress and continuing challenges. Circulation (2010) 3.32

An administrative claims measure suitable for profiling hospital performance based on 30-day all-cause readmission rates among patients with acute myocardial infarction. Circ Cardiovasc Qual Outcomes (2011) 3.31

Bayesian methods affirm the use of percutaneous coronary intervention to improve survival in patients with unprotected left main coronary artery disease. Circulation (2013) 3.30

Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med (2008) 3.29

Conditioning on the propensity score can result in biased estimation of common measures of treatment effect: a Monte Carlo study. Stat Med (2007) 3.20

Medical morbidity, mental illness, and substance use disorders. Psychiatr Serv (2002) 3.15

Nonemergency PCI at hospitals with or without on-site cardiac surgery. N Engl J Med (2013) 2.98

Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study. Arch Intern Med (2009) 2.96

Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis. BMJ (2006) 2.71

Measuring performance for treating heart attacks and heart failure: the case for outcomes measurement. Health Aff (Millwood) (2007) 2.62

Quality measurement in adult cardiac surgery: part 1--Conceptual framework and measure selection. Ann Thorac Surg (2007) 2.60

Quality measurement in adult cardiac surgery: part 2--Statistical considerations in composite measure scoring and provider rating. Ann Thorac Surg (2007) 2.59

Regionalization and the underuse of angiography in the Veterans Affairs Health Care System as compared with a fee-for-service system. N Engl J Med (2003) 2.57

Comparison of clinical and administrative data sources for hospital coronary artery bypass graft surgery report cards. Circulation (2007) 2.55

Cardiac rehabilitation and survival in older coronary patients. J Am Coll Cardiol (2009) 2.45

Reader's guide to critical appraisal of cohort studies: 1. Role and design. BMJ (2005) 2.43

Massachusetts cardiac surgery report card: implications of statistical methodology. Ann Thorac Surg (2005) 2.40

National patterns of risk-standardized mortality and readmission for acute myocardial infarction and heart failure. Update on publicly reported outcomes measures based on the 2010 release. Circ Cardiovasc Qual Outcomes (2010) 2.33

An administrative claims model for profiling hospital 30-day mortality rates for pneumonia patients. PLoS One (2011) 2.22

Hospital volume and 30-day mortality for three common medical conditions. N Engl J Med (2010) 2.20

The performance of US hospitals as reflected in risk-standardized 30-day mortality and readmission rates for medicare beneficiaries with pneumonia. J Hosp Med (2010) 2.20

The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3--valve plus coronary artery bypass grafting surgery. Ann Thorac Surg (2009) 2.18

Effects of treatment recommendations and specialist intervention on care provided by primary care physicians to patients with myocardial infarction or heart failure. Am J Med (2004) 2.15

National trends in outcomes among elderly patients with heart failure. Am J Med (2006) 2.13

ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction). Circulation (2006) 2.12

American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care. Circulation (2005) 2.10

Development, validation, and results of a measure of 30-day readmission following hospitalization for pneumonia. J Hosp Med (2011) 2.09

Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia. JAMA (2013) 2.06

Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions. Am Heart J (2010) 2.00

"America's Best Hospitals" in the treatment of acute myocardial infarction. Arch Intern Med (2007) 1.96

Coronary artery spatial distribution of acute myocardial infarction occlusions. Circulation (2004) 1.96

"Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. J Am Soc Nephrol (2004) 1.94

Getting the methods right--the foundation of patient-centered outcomes research. N Engl J Med (2012) 1.92

Likelihood methods for treatment noncompliance and subsequent nonresponse in randomized trials. Biometrics (2005) 1.91

Comparison of hospital risk-standardized mortality rates calculated by using in-hospital and 30-day models: an observational study with implications for hospital profiling. Ann Intern Med (2012) 1.90

ACC/AHA Clinical Performance Measures for Adults with Chronic Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures): endorsed by the Heart Failure Society of America. Circulation (2005) 1.90

Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practice. Arch Intern Med (2012) 1.89

Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. BMJ (2005) 1.84

Improvement in mortality risk prediction after percutaneous coronary intervention through the addition of a "compassionate use" variable to the National Cardiovascular Data Registry CathPCI dataset: a study from the Massachusetts Angioplasty Registry. J Am Coll Cardiol (2011) 1.84

Automated surveillance to detect postprocedure safety signals of approved cardiovascular devices. JAMA (2010) 1.83

Performance measurement in the small office practice: challenges and potential solutions. Ann Intern Med (2008) 1.80

Longitudinal profiling of health care units based on continuous and discrete patient outcomes. Biostatistics (2005) 1.79

Comparison of "risk-adjusted" hospital outcomes. Circulation (2008) 1.78

ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures) endorsed by the Heart Failure Society of America. J Am Coll Cardiol (2005) 1.76

The volume-outcome relationship: from Luft to Leapfrog. Ann Thorac Surg (2003) 1.76

ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction). J Am Coll Cardiol (2006) 1.74

Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts. Circulation (2008) 1.68

Atypical antipsychotics and parkinsonism. Arch Intern Med (2005) 1.66

Comparative assessment of implantable hip devices with different bearing surfaces: systematic appraisal of evidence. BMJ (2011) 1.63

Acute myocardial infarction and congestive heart failure outcomes at specialty cardiac hospitals. Circulation (2007) 1.61

Implementation of a cardiac surgery report card: lessons from the Massachusetts experience. Ann Thorac Surg (2005) 1.58

The medical treatment of depression, 1991-1996: productive inefficiency, expected outcome variations, and price indexes. J Health Econ (2002) 1.55

Differences in patient survival after acute myocardial infarction by hospital capability of performing percutaneous coronary intervention: implications for regionalization. Arch Intern Med (2010) 1.52

Is same-hospital readmission rate a good surrogate for all-hospital readmission rate? Med Care (2010) 1.51

Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention. JAMA (2013) 1.51

Vascular closure device failure in contemporary practice. JACC Cardiovasc Interv (2012) 1.50

Associations between adherence to guidelines for antipsychotic dose and health status, side effects, and patient care experiences. Med Care (2006) 1.50

Quality of care in the US territories. Arch Intern Med (2011) 1.49

Long-term clinical outcomes following drug-eluting or bare-metal stent placement in patients with severely reduced GFR: Results of the Massachusetts Data Analysis Center (Mass-DAC) State Registry. Am J Kidney Dis (2010) 1.46

Racial and ethnic service use disparities among homeless adults with severe mental illnesses receiving ACT. Psychiatr Serv (2011) 1.43

Correlated bivariate continuous and binary outcomes: issues and applications. Stat Med (2009) 1.43

Warfarin prescribing in atrial fibrillation: the impact of physician, patient, and hospital characteristics. Am J Med (2006) 1.40

Drug-eluting stents versus bare metal stents prior to noncardiac surgery. Catheter Cardiovasc Interv (2014) 1.39

Externally caused deaths for adults with substance use and mental disorders. J Behav Health Serv Res (2004) 1.37

Intent-to-Treat vs. Non-Intent-to-Treat Analyses under Treatment Non-Adherence in Mental Health Randomized Trials. Psychiatr Ann (2008) 1.36

Socioeconomic disparities in outcomes after acute myocardial infarction. Am Heart J (2007) 1.36

The effects of mental health parity on spending and utilization for bipolar, major depression, and adjustment disorders. Am J Psychiatry (2013) 1.34

Quality of care for the treatment of acute medical conditions in US hospitals. Arch Intern Med (2006) 1.33

Impact of full mental health and substance abuse parity for children in the Federal Employees Health Benefits Program. Pediatrics (2007) 1.33

Public reporting of 30-day mortality for patients hospitalized with acute myocardial infarction and heart failure. Circulation (2008) 1.30

Low-volume coronary artery bypass surgery: measuring and optimizing performance. J Thorac Cardiovasc Surg (2008) 1.29

Variation in hospital mortality rates for patients with acute myocardial infarction. Am J Cardiol (2010) 1.28

Public reporting of cardiac surgery performance: Part 1--history, rationale, consequences. Ann Thorac Surg (2011) 1.28

Does prospective payment reduce inpatient length of stay? Health Econ (2002) 1.28

Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement. J Clin Psychiatry (2010) 1.27

Geographic disparities in the incidence and outcomes of hospitalized myocardial infarction: does a rising tide lift all boats? Circ Cardiovasc Qual Outcomes (2012) 1.25

Standards for measures used for public reporting of efficiency in health care: a scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research and the American College of Cardiology Foundation. Circulation (2008) 1.25